Owlet (OWLT) EBT Margin Growth (3y) (2023 - 2026)

Owlet (OWLT) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -305.00
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -9.00
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 55.00
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 923.00
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -480.00
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 1,391.00
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2,114.00
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -176.00
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Owlet 147.80 Mn 106.79 Mn 12.24 Mn 9,571.00

Historic Data

Download Data
DateValue
Mar 31, 2026 9,571.00
Dec 31, 2025 12,836.00
Sep 30, 2025 12,452.00
Jun 30, 2025 -8,060.00
Mar 31, 2025 14,788.00
Dec 31, 2024 -100,136.00
Sep 30, 2024 8,396.00
Jun 30, 2024 1,595.00
Mar 31, 2024 5,803.00
Dec 31, 2023 633.00
Sep 30, 2023 -5,434.00